Item 4 — Purpose of Transaction
The securities currently held, as reported herein, are being held for investment purposes. The Reporting Person has entered a voluntary plan of liquidation and appointed Dr. Pedro Palau as the legal representative in place of the board of directors of the Reporting Person, as of February 1, 2025. The general mandate of Dr. Palau, as liquidator, is to repay creditors and then distribute the assets of the Reporting Person to its constituent parties. In the context of the administration of the liquidation, the Reporting Person will review its investment in the issuer and will monitor a wide variety of investment considerations, including, without limitation, current and anticipated future trading prices for the Common Stock, the issuer's financial position, operations, assets, prospects, strategic direction and business and other developments affecting the issuer. The Reporting Person will also evaluate its cash requirements for its operating expenses, which may require Reporting Person to sell some of the shares of Common Stock in the issuer, prior to any distribution of the remaining assets to its constituent parties. The Reporting Person may from time to time take those actions with respect to its investment in the issuer as it deems appropriate, including, without limitation, (i) acquiring or disposing Common Stock of the issuer (or other securities of the issuer, if any), including exercising of any outstanding Common Stock derivative securities that it may hold; (ii) changing its current intentions with respect to any or all matters referred to in this Item 4; and/or (iii) engaging in hedging, derivative or similar transactions with respect to any securities of the issuer, all taking into account any trading and reporting restrictions then applicable. As a shareholder of the issuer, the Reporting Person may propose and encourage or vote for the issuer to engage in acquisition and disposition transactions and to enter into financing transactions that may change the capitalization of the issuer. Any acquisition or disposition of the issuer's securities may be made by means of open-market transactions, privately negotiated transactions, or direct transactions with the Issuer. At the date of this amendment to the Schedule 13D, except as set forth in this Schedule 13D, as amended, and publicly announced by the issuer, the Reporting Person does not have any plans or proposals that it would take unilaterally that would result in: (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the issuer or of any of its subsidiaries; (d) Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the issuer; (f) Any other material change in the Issuer's business or corporate structure; (g) Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above.